![Open Access](/resources/images/iconopenaccess.png)
Effects of icariin on cell injury and glucocorticoid resistance in BEAS‑2B cells exposed to cigarette smoke extract
- Authors:
- Lingli Hu
- Feng Liu
- Lulu Li
- Li Zhang
- Chen Yan
- Qiuping Li
- Jian Qiu
- Jingcheng Dong
- Jing Sun
- Hongying Zhang
-
Affiliations: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, Department of Rehabilitation, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China - Published online on: April 29, 2020 https://doi.org/10.3892/etm.2020.8702
- Pages: 283-292
-
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
![]() |
![]() |
![]() |
![]() |
Mathers CD and Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3(e442)2006.PubMed/NCBI View Article : Google Scholar | |
Hanania NA and Marciniuk DD: A unified front against COPD: Clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society. Chest. 140:565–566. 2011.PubMed/NCBI View Article : Google Scholar | |
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 176:532–555. 2007.PubMed/NCBI View Article : Google Scholar | |
Aghapour M, Raee P, Moghaddam SJ, Hiemstra PS and Heijink IH: Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: Role of cigarette smoke exposure. Am J Respir Cell Mol Biol. 58:157–169. 2018.PubMed/NCBI View Article : Google Scholar | |
Ng DS, Liao W, Tan WS, Chan TK, Loh XY and Wong WS: Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine. 21:1638–1644. 2014.PubMed/NCBI View Article : Google Scholar | |
Murray LA, Dunmore R, Camelo A, Da Silva CA, Gustavsson MJ, Habiel DM, Hackett TL, Hogaboam CM, Sleeman MA and Knight DA: Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium. Respir Res. 18(82)2017.PubMed/NCBI View Article : Google Scholar | |
Huang AX, Lu LW, Liu WJ and Huang M: Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-α levels correlate with pulmonary function in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome. Med Sci Monit. 22:2800–2808. 2016.PubMed/NCBI View Article : Google Scholar | |
Wang C, Li Z, Liu X, Peng Q, Li F, Li D and Wang C: Effect of Liuweibuqi capsule, a Chinese patent medicine, on the JAK1/STAT3 pathway and MMP9/TIMP1 in a chronic obstructive pulmonary disease rat model. J Tradit Chin Med. 35:54–62. 2015.PubMed/NCBI View Article : Google Scholar | |
Marushchak M, Maksiv K and Krynytska I: The specific features of free radical oxidation in patients with chronic obstructive pulmonary disease and arterial hypertension. Pol Merkur Lekarski. 47:95–98. 2019.PubMed/NCBI | |
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald JM, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 31:143–178. 2008.PubMed/NCBI View Article : Google Scholar | |
Barnes PJ, Greening AP and Crompton GK: Glucocorticoid resistance in asthma. Am J Respir Crit Care Med. 152 (Suppl):S125–S140. 1995.PubMed/NCBI View Article : Google Scholar | |
Burmester GR and Pope JE: Novel treatment strategies in rheumatoid arthritis. Lancet. 389:2338–2348. 2017.PubMed/NCBI View Article : Google Scholar | |
Baumgart DC and Sandborn WJ: Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet. 369:1641–1657. 2007.PubMed/NCBI View Article : Google Scholar | |
Torres J, Mehandru S, Colombel JF and Peyrin-Biroulet L: Crohn's disease. Lancet. 389:1741–1755. 2017.PubMed/NCBI View Article : Google Scholar | |
Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, et al: The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohn's Colitis. 4:28–62. 2010.PubMed/NCBI View Article : Google Scholar | |
Rhen T and Cidlowski JA: Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med. 353:1711–1723. 2005.PubMed/NCBI View Article : Google Scholar | |
Barnes PJ: New therapies for chronic obstructive pulmonary disease. Med Princ Pract. 19:330–338. 2010.PubMed/NCBI View Article : Google Scholar | |
Morjaria JB, Malerba M and Polosa R: Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD. Drug Discov Today. 15:396–405. 2010.PubMed/NCBI View Article : Google Scholar | |
Barnes PJ: How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol. 148:245–254. 2006.PubMed/NCBI View Article : Google Scholar | |
Rodriguez JM, Monsalves-Alvarez M, Henriquez S, Llanos MN and Troncoso R: Glucocorticoid resistance in chronic diseases. Steroids. 115:182–192. 2016.PubMed/NCBI View Article : Google Scholar | |
Barnes PJ and Adcock IM: Glucocorticoid resistance in inflammatory diseases. Lancet. 373:1905–1917. 2009.PubMed/NCBI View Article : Google Scholar | |
Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM and Barnes PJ: Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 200:689–695. 2004.PubMed/NCBI View Article : Google Scholar | |
Barnes PJ, Ito K and Adcock IM: Corticosteroid resistance in chronic obstructive pulmonary disease: Inactivation of histone deacetylase. Lancet. 363:731–733. 2004.PubMed/NCBI View Article : Google Scholar | |
Zhou Z, Zheng W, Liang T, Yan Q, Zhang C, Huang H, Liu X and Ye X: Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis protocol. Medicine (Baltimore). 99(e18620)2020.PubMed/NCBI View Article : Google Scholar | |
Zhao YL, Song HR, Fei JX, Liang Y, Zhang BH, Liu QP, Wang J and Hu P: The effects of Chinese yam-epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease. J Tradit Chin Med. 32:203–207. 2012.PubMed/NCBI View Article : Google Scholar | |
He W, Sun H, Yang B, Zhang D and Kabelitz D: Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung. 45:910–913. 1995.PubMed/NCBI | |
Shi Y, Yan WH, Lin QY and Wang WM: Icariin influences cardiac remodeling following myocardial infarction by regulating the CD147/MMP-9 pathway. J Int Med Res. 46:2371–2385. 2018.PubMed/NCBI View Article : Google Scholar | |
Dong H, Ming S, Fang J, Li Y and Liu L: Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation. Hum Cell. 32:22–30. 2019.PubMed/NCBI View Article : Google Scholar | |
Ming LG, Chen KM and Xian CJ: Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol. 228:513–521. 2013.PubMed/NCBI View Article : Google Scholar | |
Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao YX and Dong JC: Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol. 642:146–153. 2010.PubMed/NCBI View Article : Google Scholar | |
Chen SR, Xu XZ, Wang YH, Chen JW, Xu SW, Gu LQ and Liu PQ: Icariin derivative inhibits inflammation through suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways. Biol Pharm Bull. 33:1307–1313. 2010.PubMed/NCBI View Article : Google Scholar | |
Wu J, Xu H, Wong PF, Xia S, Xu J and Dong J: Icaritin attenuates cigarette smoke-mediated oxidative stress in human lung epithelial cells via activation of PI3K-AKT and Nrf2 signaling. Food Chem Toxicol. 64:307–313. 2014.PubMed/NCBI View Article : Google Scholar | |
Krystosek A and Sachs L: Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell. 9:675–684. 1976.PubMed/NCBI View Article : Google Scholar | |
Hu L, Yu Y, Huang H, Fan H, Hu L, Yin C, Li K, Fulton DJ and Chen F: Epigenetic regulation of interleukin 6 by histone acetylation in macrophages and its role in paraquat-induced pulmonary Fibrosis. Front Immunol. 7(696)2017.PubMed/NCBI View Article : Google Scholar | |
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar | |
Papakonstantinou E, Karakiulakis G, Batzios S, Savic S, Roth M, Tamm M and Stolz D: Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection. Respir Res. 16(78)2015.PubMed/NCBI View Article : Google Scholar | |
Navratilova Z, Kolek V and Petrek M: Matrix metalloproteinases and their inhibitors in chronic obstructive pulmonary disease. Arch Immunol Ther Exp (Warsz). 64:177–193. 2016.PubMed/NCBI View Article : Google Scholar | |
Vandewalle J, Luypaert A, De Bosscher K and Libert C: Therapeutic mechanisms of glucocorticoids. Trends Endocrinol Metab. 29:42–54. 2018.PubMed/NCBI View Article : Google Scholar | |
Li J, Liu D, Wu J, Zhang D, Cheng B, Zhang Y, Yin Z, Wang Y, Du J and Ling C: Ginsenoside Rg1 attenuates ultraviolet B-induced glucocortisides resistance in keratinocytes via Nrf2/HDAC2 signalling. Sci Rep. 6(39336)2016.PubMed/NCBI View Article : Google Scholar | |
Stabile AM, Marinucci L, Balloni S, Giuliani A, Pistilli A, Bodo M and Rende M: Long term effects of cigarette smoke extract or nicotine on nerve growth factor and its receptors in a bronchial epithelial cell line. Toxicol In Vitro. 53:29–36. 2018.PubMed/NCBI View Article : Google Scholar | |
Munakata S, Ishimori K, Kitamura N, Ishikawa S, Takanami Y and Ito S: Oxidative stress responses in human bronchial epithelial cells exposed to cigarette smoke and vapor from tobacco- and nicotine-containing products. Regul Toxicol Pharmacol. 99:122–128. 2018.PubMed/NCBI View Article : Google Scholar | |
Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK and Balmes JR: Committee on Nonsmoking COPD Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182:693–718. 2010.PubMed/NCBI View Article : Google Scholar | |
Lee H, Jung KH, Park S, Kil YS, Chung EY, Jang YP, Seo EK and Bae H: Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse model. BMC Complement Altern Med. 14(513)2014.PubMed/NCBI View Article : Google Scholar | |
Ramos CO, Campos KKD, Costa GP, Cangussú SD, Talvani A and Bezerra FS: Taurine treatment decreases inflammation and oxidative stress in lungs of adult mice exposed to cigarette smoke. Regul Toxicol Pharmacol. 98:50–57. 2018.PubMed/NCBI View Article : Google Scholar | |
Chen L, Ge Q, Tjin G, Alkhouri H, Deng L, Brandsma CA, Adcock I, Timens W, Postma D, Burgess JK, et al: Effects of cigarette smoke extract on human airway smooth muscle cells in COPD. Eur Respir J. 44:634–646. 2014.PubMed/NCBI View Article : Google Scholar | |
BéruBé K, Aufderheide M, Breheny D, Clothier R, Combes R, Duffin R, Forbes B, Gaça M, Gray A, Hall I, et al: In vitro models of inhalation toxicity and disease The report of a FRAME workshop. Altern Lab Anim. 37:89–141. 2009.PubMed/NCBI | |
López-Rodríguez JC, Benedé S, Barderas R, Villalba M and Batanero E: Airway epithelium plays a leading role in the complex framework underlying respiratory allergy. J Investig Allergol Clin Immunol. 27:346–355. 2017.PubMed/NCBI View Article : Google Scholar | |
Gras D, Chanez P, Vachier I, Petit A and Bourdin A: Bronchial epithelium as a target for innovative treatments in asthma. Pharmacol Ther. 140:290–305. 2013.PubMed/NCBI View Article : Google Scholar | |
Pouli AE, Hatzinikolaou DG, Piperi C, Stavridou A, Psallidopoulos MC and Stavrides JC: The cytotoxic effect of volatile organic compounds of the gas phase of cigarette smoke on lung epithelial cells. Free Radic Biol Med. 34:345–355. 2003.PubMed/NCBI View Article : Google Scholar | |
Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK and Dixit RK: Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett. 196:1–10. 2018.PubMed/NCBI View Article : Google Scholar | |
Zhang X, Zheng H, Zhang H, Ma W, Wang F, Liu C and He S: Increased interleukin (IL)-8 and decreased IL-17 production in chronic obstructive pulmonary disease (COPD) provoked by cigarette smoke. Cytokine. 56:717–725. 2011.PubMed/NCBI View Article : Google Scholar | |
Schneider D, Ganesan S, Comstock AT, Meldrum CA, Mahidhara R, Goldsmith AM, Curtis JL, Martinez FJ, Hershenson MB and Sajjan U: Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182:332–340. 2010.PubMed/NCBI View Article : Google Scholar | |
de Godoy I, Donahoe M, Calhoun WJ, Mancino J and Rogers RM: Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med. 153:633–637. 1996.PubMed/NCBI View Article : Google Scholar | |
Xie J, Yang XY, Shi JD, Deng XQ and Long W: A new inflammation marker of chronic obstructive pulmonary disease-adiponectin. World J Emerg Med. 1:190–195. 2010.PubMed/NCBI | |
Barnes PJ: Therapy of chronic obstructive pulmonary disease. Pharmacol Ther. 97:87–94. 2003.PubMed/NCBI View Article : Google Scholar | |
Wu H, Yang S, Wu X, Zhao J, Zhao J, Ning Q, Xu Y and Xie J: Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice. Biochem Biophys Res Commun. 450:110–116. 2014.PubMed/NCBI View Article : Google Scholar | |
Malaviya R, Laskin JD and Laskin DL: Anti-TNFα therapy in inflammatory lung diseases. Pharmacol Ther. 180:90–98. 2017.PubMed/NCBI View Article : Google Scholar | |
Zhang L, Cheng Z, Liu W and Wu K: Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD. 10:459–465. 2013.PubMed/NCBI View Article : Google Scholar | |
Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C and Godoy I: Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. Am J Med Sci. 345:440–445. 2013.PubMed/NCBI View Article : Google Scholar | |
Mercer PF, Shute JK, Bhowmik A, Donaldson GC, Wedzicha JA and Warner JA: MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res. 6(151)2005.PubMed/NCBI View Article : Google Scholar | |
Yao H, Hwang JW, Sundar IK, Friedman AE, McBurney MW, Guarente L, Gu W, Kinnula VL and Rahman I: SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. Am J Physiol Lung Cell Mol Physiol. 305:L615–L624. 2013.PubMed/NCBI View Article : Google Scholar | |
Greenlee KJ, Werb Z and Kheradmand F: Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol Rev. 87:69–98. 2007.PubMed/NCBI View Article : Google Scholar | |
Tiede SL, Wassenberg M, Christ K, Schermuly RT, Seeger W, Grimminger F, Ghofrani HA and Gall H: Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension. Int J Cardiol. 223:821–826. 2016.PubMed/NCBI View Article : Google Scholar | |
Vogel ER, Britt RD Jr, Faksh A, Kuipers I, Pandya H, Prakash YS, Martin RJ and Pabelick CM: Moderate hyperoxia induces extracellular matrix remodeling by human fetal airway smooth muscle cells. Pediatr Res. 81:376–383. 2017.PubMed/NCBI View Article : Google Scholar | |
MacDougall JR and Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14:351–362. 1995.PubMed/NCBI View Article : Google Scholar | |
Yao PM, Buhler JM, d'Ortho MP, Lebargy F, Delclaux C, Harf A and Lafuma C: Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem. 271:15580–15589. 1996.PubMed/NCBI View Article : Google Scholar | |
LeBert DC, Squirrell JM, Rindy J, Broadbridge E, Lui Y, Zakrzewska A, Eliceiri KW, Meijer AH and Huttenlocher A: Matrix metalloproteinase 9 modulates collagen matrices and wound repair. Development. 142:2136–2146. 2015.PubMed/NCBI View Article : Google Scholar | |
Linder R, Rönmark E, Pourazar J, Behndig A, Blomberg A and Lindberg A: Serum metalloproteinase-9 is related to COPD severity and symptoms-cross-sectional data from a population based cohort-study. Respir Res. 16(28)2015.PubMed/NCBI View Article : Google Scholar | |
Chaudhuri R, McSharry C, Spears M, Brady J, Grierson C, Messow CM, Miele G, Nocka K, MacNee W, Connell M, et al: Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD. Transl Respir Med. 1(11)2013.PubMed/NCBI View Article : Google Scholar | |
Lambert E, Dassé E, Haye B and Petitfrère E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 49:187–198. 2004.PubMed/NCBI View Article : Google Scholar | |
Toricelli M, Melo FH, Peres GB, Silva DC and Jasiulionis MG: Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol Cancer. 12(22)2013.PubMed/NCBI View Article : Google Scholar | |
Arpino V, Brock M and Gill SE: The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 44-46:247–254. 2015.PubMed/NCBI View Article : Google Scholar | |
Mocchegiani E, Giacconi R and Costarelli L: Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: Genetic factors and treatment implications. Curr Opin Pulm Med. 17 (Suppl 1):S11–S19. 2011.PubMed/NCBI View Article : Google Scholar | |
Pryor WA and Stone K: Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci. 686:12–27; discussion 27-28. 1993.PubMed/NCBI View Article : Google Scholar | |
Boukhenouna S, Wilson MA, Bahmed K and Kosmider B: Reactive oxygen species in chronic obstructive pulmonary disease. Oxid Med Cell Longev. 2018(5730395)2018.PubMed/NCBI View Article : Google Scholar | |
Jiang Y, Wang X and Hu D: Mitochondrial alterations during oxidative stress in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 12:1153–1162. 2017.PubMed/NCBI View Article : Google Scholar | |
MacNee W: Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2:50–60. 2005.PubMed/NCBI View Article : Google Scholar | |
Barnes PJ: Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 120:76–85. 2010.PubMed/NCBI View Article : Google Scholar | |
Ingawale DK, Mandlik SK and Patel SS: An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance. J Complement Integr Med. 12:1–13. 2015.PubMed/NCBI View Article : Google Scholar | |
Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ and Adcock IM: Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med. 203:7–13. 2006.PubMed/NCBI View Article : Google Scholar | |
Payne DN and Adcock IM: Molecular mechanisms of corticosteroid actions. Paediatr Respir Rev. 2:145–150. 2001.PubMed/NCBI View Article : Google Scholar | |
Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG and Glass CK: Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell. 122:707–721. 2005.PubMed/NCBI View Article : Google Scholar | |
Li L, Sun J, Xu C, Zhang H, Wu J, Liu B and Dong J: Icariin ameliorates cigarette smoke induced inflammatory responses via suppression of NF-κB and modulation of GR in vivo and in vitro. PLoS One. 9(e102345)2014.PubMed/NCBI View Article : Google Scholar |